Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class ASSE: 603392

Announcement on Initiating Phase III Clinical Trial of 9-valent HPV Vaccine for Men and Completing the Enrollment of First Subject

· Issued by Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Initiating Phase III Clinical Trial of 9-valent HPV Vaccine for Men and Completing the Enrollment of First Subject

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis